Perinatal cerebral asphyxia: pharmacological intervention

Fetal Ther. 1988;3(1-2):98-107. doi: 10.1159/000263339.

Abstract

Perinatal asphyxia is associated with an increased risk of cerebral palsy and significant mortality. We investigated the use of flunarizine, a calcium antagonist and MK-801, an excitatory amino acid antagonist, in preventing the sequelae of severe hypoxic/ischemic insults. Flunarizine was neuroprotective in the infant rat subjected to unilateral carotid ligation and 2 h of hypoxia. Preliminary analysis of experiments in a novel model of cerebral ischemia in the fetal sheep suggests that prophylactic treatment with flunarizine greatly modified the outcome after 30 min of total ischemia. Treatment with MK-801 prevented post-ischemic seizures. The background to these developments is outlined and future prospects considered.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anticonvulsants / therapeutic use*
  • Dibenzocycloheptenes / therapeutic use*
  • Disease Models, Animal
  • Dizocilpine Maleate
  • Female
  • Fetal Diseases / drug therapy*
  • Flunarizine / therapeutic use*
  • Hypoxia, Brain / drug therapy*
  • Pregnancy
  • Rats
  • Seizures / prevention & control
  • Sheep

Substances

  • Anticonvulsants
  • Dibenzocycloheptenes
  • Dizocilpine Maleate
  • Flunarizine